Dr. David Carlson, Nuclear Medicine Physician, Ridley-Tree Cancer Center and Dr. William Pace, Nuclear Medicine Physician, Ridley-Tree Cancer Center. (courtesy photo) The Ridley-Tree Cancer Center pioneers many breakthroughs in nuclear oncology, and their latest is focused on treating prostate cancer earlier than ever before thanks to a new federal approval of Pluvicto’s injectable radioligand therapy…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
